NASA to Discuss Firefly's First Robotic Artemis Moon Flight
Audio of the call will livestream on the agency's website at:
Briefing participants include:
Joel Kearns , deputy associate administrator for exploration, Science Mission Directorate, NASA HeadquartersRyan Watkins , program scientist, Exploration Science Strategy and Integration Office, NASA HeadquartersJason Kim , chief executive officer, Firefly Aerospace
To participate by telephone, media must RSVP no later than two hours before the briefing to: [email protected].
Firefly's Blue Ghost lunar lander will launch on a SpaceX Falcon 9 rocket from
The lunar mission, named Ghost Riders in the Sky, will land near a volcanic feature called Mons Latreille within Mare Crisium, a more than 300-mile-wide basin located in the northeast quadrant of the Moon's near side. The mission will carry 10 NASA instruments and first-of-their-kind demonstrations to further our understanding of the Moon's environment and help prepare for future human missions to the lunar surface, as part of the agency's Moon to Mars exploration approach.
Science investigations on this flight include testing lunar subsurface drilling, regolith sample collection, global navigation satellite system abilities, radiation tolerant computing, and lunar dust mitigation. The data captured could also benefit humans on Earth by providing insights into how space weather and other cosmic forces impact Earth.
Under the CLPS model, NASA is investing in commercial delivery services to the Moon to enable industry growth and support long-term lunar exploration. As a primary customer for CLPS deliveries, NASA is to be one of many customers on future flights.
For updates, follow on:
https://blogs.nasa.gov/artemis/
View original content to download multimedia:https://www.prnewswire.com/news-releases/nasa-to-discuss-fireflys-first-robotic-artemis-moon-flight-302328122.html
SOURCE NASA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
- New Zealand Energy Corp. Provides Corporate Update
- TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share